Brief: Cleo Diagnostics Seeks Trading Halt
02/11/2023 23:48
Nov 3 (Reuters) - Cleo Diagnostics COV.AX :
* SEEKS TRADING HALT PENDING ANNOUNCEMENT ON RESULTS OF
CLEO'S
FIRST CLINICAL VALIDATION STUDY FOR TRIAGE TEST
Source text for Eikon: ID:nASX2XC61s
Further company coverage: COV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CLEO Diagnostics
See all newsAustralia's Cleo Diagnostics jumps after cancer screening test meets milestone
Brief: Cleo Diagnostics Files Patents For Its Ovarian Cancer Screening Test
Australia's Cleo Diagnostics jumps as ovarian cancer test hits validation milestone
Brief: Cleo Diagnostics Receives First Batch Of Commercially Manufactured Test Kits
Brief: Cleo Diagnostics Raises A$5M